Brief: Sensorion Receives European Authorization To Start Sens-401 Phase 2 Trial In Sudden Sensorineural Hearing Loss

Sensorion SA

20/08/2018 06:33

Aug 20 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION RECEIVES EUROPEAN AUTHORIZATION TO INITIATE
SENS-401
PHASE 2 TRIAL IN SUDDEN SENSORINEURAL HEARING LOSS
    * INTERNATIONAL MULTICENTER PHASE 2 WITH SENS-401 FOR
TREATING
SUDDEN SENSORINEURONAL HEARING LOSS IN ADULTS TO START
    * SENSORION'S 2ND EUROPEAN VOLUNTARY HARMONIZATION PROCEDURE
APPLICATION APPROVAL
    * PHASE 2 STUDY WILL BE CONDUCTED ACROSS 50 SITES IN EUROPE,
U.S.,
CANADA, ISRAEL, AND TURKEY, AND ENROLL ABOUT 260 PATIENTS
    * COMPANY AIMS FOR PHASE 2 STUDY START (FIRST PATIENT IN) IN
Q4
2018, AND INTERIM TOPLINE DATA IN Q4 2019

Source text for Eikon:  ID:nBw47JCF9a 
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))